Pranlukast Tablets 225mg “CEO” by Ceolia Pharma (YJ code: 4490017F2050, standard: 225mg x 1 tablet) contains Pranlukast Hydrate, a leukotriene receptor antagonist. It is typically used for conditions such as bronchial asthma and allergic rhinitis, working to improve symptoms by inhibiting leukotriene activity.
Pranlukast Tablets 225mg “CEO”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
